Clinical Trials Sponsored by Inotec AMD Limited

Total 243 results

Inotec AMD Limited

Withdrawn

Pilot Study Comparing NatroxTM Topical Oxygen Therapy to A Placebo in the Management of Non-Healing Leg Ulcers

Skin Ulcer Venous Stasis Chronic | Mixed Arteriovenous Leg Ulcer

Czechia
Inotec AMD Limited
SerenaGroup, Inc.

Completed

The Effect of Natrox® Oxygen Wound Therapy on the Healing Rate of Chronic Diabetic Foot Ulcers

Surgical Wound | Diabetic Foot Ulcer

United States, Puerto Rico
Inotec AMD Limited
Salem VA Medical Center

Completed

Effect of Natrox Oxygen Wound Therapy on Non-healing Wounds and Implication of Remote Monitoring and Telehealth for Management in the Home.

Non-healing Wounds

United States
Tibotec BVBA
Tibotec Pharmaceutical Limited

Completed

A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment

Hepatitis C, Chronic

United States, Australia, France, United Kingdom, Germany, Spain, Belgium, Israel, Canada, Brazil, Austria, Poland, Netherlands, Sweden, Switzerland, Puerto Rico
Tibotec Pharmaceuticals, Ireland
Tibotec Pharmaceutical Limited

Completed

A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents (DIONE)

HIV-1 Infection

France, United States, Spain, Ukraine, United Kingdom, Ireland
Tibotec Pharmaceuticals, Ireland
Tibotec Pharmaceutical Limited

Completed

A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected Children

Human Immunodeficiency Virus 1

South Africa, Argentina, Brazil, India, Kenya
Inotrem
Richmond Pharmacology Limited

Completed

Safety, Tolerability and Pharmacokinetic Profiles of MOTREM (LR12) in Healthy Male Subjects

Healthy Subjects

United Kingdom
Evotec Neurosciences GmbH
Richmond Pharmacology Limited

Completed

The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function

Human Volunteers

United Kingdom
Vertex Pharmaceuticals Incorporated
Tibotec Pharmaceutical Limited

Completed

A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)

Hepatitis C

Australia, Canada, France, Italy, Poland, United Kingdom, Germany, United States, Spain, Israel, Argentina, Puerto Rico, Austria
Vertex Pharmaceuticals Incorporated
Tibotec Pharmaceutical Limited

Completed

Virology Follow up Study in Subjects Previously Treated With Telaprevir

Hepatitis C

United States, France, Canada, Germany, Puerto Rico
Vertex Pharmaceuticals Incorporated
Tibotec Pharmaceutical Limited

Completed

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

Hepatitis C

Belgium, United States, Puerto Rico, Netherlands
Vertex Pharmaceuticals Incorporated
Tibotec Pharmaceutical Limited

Completed

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

HIV Infections | Hepatitis C

France, Spain, United States, Germany
Geriatric Oncology Consortium
Tibotec Pharmaceutical Limited

Terminated

Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients

Non-Hodgkin's Lymphoma

United States
Vertex Pharmaceuticals Incorporated
Tibotec Pharmaceutical Limited

Completed

A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults

Hepatitis C

United States
International Partnership for Microbicides, Inc.
Tibotec Pharmaceutical Limited

Completed

Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)

HIV Infections

Belgium
International Partnership for Microbicides, Inc.
Tibotec Pharmaceutical Limited

Completed

Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium

HIV Infections

Belgium
Community Research Initiative of New England
Tibotec Pharmaceutical Limited

Completed

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r (LARD)

HIV Infections

United States
University of North Carolina, Chapel Hill
Tibotec Pharmaceutical Limited

Completed

Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling

Hepatitis C

United States
US Oncology Research
Ortho Biotech, Inc.; Tibotec Pharmaceutical Limited

Completed

Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
University of North Carolina, Chapel Hill
Tibotec Pharmaceutical Limited

Completed

Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue (DESeRT)

HIV Infections | HIV/AIDS

United States
China National Biotec Group Company Limited
Sichuan Center for Disease Control and Prevention

Completed

A Clinical Trial to Evaluate the Immunogenicity and Safety of PPV23 Vaccine Revaccinations in the Elderly

Vaccination

China
Sichuan Center for Disease Control and Prevention
China National Biotec Group Company Limited

Unknown

The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine

Rotavirus
Sichuan Center for Disease Control and Prevention
China National Biotec Group Company Limited

Completed

Post-License Safety Evaluation of Influenza Virus Vaccine

Influenza | Adverse Drug Event
AMO Pharma Limited

Completed

Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy

Congenital Myotonic Dystrophy

United States, Canada, New Zealand, Australia, United Kingdom
AMO Pharma Limited

Completed

Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy

Myotonic Dystrophy 1

United Kingdom
AMO Pharma Limited

Recruiting

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy (REACH CDM X)

Congenital Myotonic Dystrophy

United States, Canada, Australia, New Zealand
Dallas VA Medical Center
Merck Sharp & Dohme LLC; Tibotec Pharmaceutical Limited

Completed

Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients (RADAR)

HIV Infections

United States
Shanghai Municipal Center for Disease Control and...
China National Biotec Group Company Limited

Not yet recruiting

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines

Measles | Rubella | Mumps | Varicella | SARS-CoV-2 Infection

China
Zhejiang Provincial Center for Disease Control...
China National Biotec Group Company Limited

Not yet recruiting

Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children ( DTaP/DT ) (DTaP/DT)

Vaccine Reaction

China
Zhejiang Provincial Center for Disease Control...
China National Biotec Group Company Limited

Completed

The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine

Seasonal Influenza | Hand, Foot and Mouth Disease

China
Zhejiang Provincial Center for Disease Control...
China National Biotec Group Company Limited

Not yet recruiting

Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children (DTaP/DT)

Vaccine Reaction

China
China National Biotec Group Company Limited
Shanghai Municipal Center for Disease Control and Prevention

Completed

A Clinical Trial to Evaluate the Safety and Immunogenicity of PPV23 Vaccine Revaccinated in 60-70 Years Old

Vaccination

China
Zhejiang Provincial Center for Disease Control...
China National Biotec Group Company Limited

Completed

Immunogenicity and Safety Evaluation of Different Sequential Immunization Strategies by Sabin IPV and bOPV in Chinese Infants

Polio

China
China National Biotec Group Company Limited
Shaanxi Provincial Center for Disease Control and Prevention

Unknown

Comparative Immunogenicity Study of Two Hepatitis A Vaccines

Hepatitis A

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Active, not recruiting

A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated (COVID-19)

Covid19

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Completed

Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above (COVID-19)

COVID-19 | COVID-19 Pneumonia

United Arab Emirates
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Active, not recruiting

A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTaP)

Whooping Cough | Tetanus | Diphtheria

China
French National Agency for Research on AIDS and...
Tibotec Pharmaceutical Limited

Completed

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

HIV Infections

France
Bharat Serums and Vaccines Limited

Completed

Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer

Advanced Prostate Adenocarcinoma

India
Bharat Serums and Vaccines Limited

Terminated

Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection (PROTECT)

SARS-CoV-2 Infection

India
Limited Liability Company Pharm Aid

Completed

Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.

Rotavirus Infections | Rotavirus Vaccines

Russian Federation
Bharat Serums and Vaccines Limited

Active, not recruiting

Recombinant Follicle-stimulating Hormone in Treatment for Infertility (REFRESH)

Female Infertility

India
Limited Liability Company Pharm Aid

Completed

Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization

Rotavirus Infection

Russian Federation
University of Tartu
State University of New York - Downstate Medical Center; Tibotec Pharmaceutical...

Completed

HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence

Acquired Immunodeficiency Syndrome | Medication Adherence | Acute HIV Infection

Estonia
Melanoma and Skin Cancer Trials Limited

Not yet recruiting

Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases (BETTER)

Melanoma Brain Metastases
Melanoma and Skin Cancer Trials Limited

Recruiting

Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma (I-MAT)

Neuroendocrine Tumors | Merkel Cell Carcinoma | Merkel Cell Carcinoma, Stage I | Merkel Cell Carcinoma, Stage II | Merkel Cell Carcinoma, Stage III | Carcinoma Neuroendocrine Skin

Australia, New Zealand
Melanoma and Skin Cancer Trials Limited

Recruiting

Targeted Therapy and Avelumab in Merkel Cell Carcinoma (GoTHAM)

Metastatic Merkel Cell Carcinoma

Australia
National Vaccine and Serum Institute, China
China National Biotec Group Company Limited; Lanzhou Institute of Biological...

Active, not recruiting

Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above

Coronavirus Infections | COVID-19 Pneumonia

United Arab Emirates
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Shulan (Hangzhou) Hospital

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above (COVID-19)

COVID-19

China
China National Biotec Group Company Limited
Wuhan Institute of Biological Products Co., Ltd; Hubei Provincial Center for...

Recruiting

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected

HIV Infections | COVID-19

China

Clinical Trials Sponsored by Inotec AMD Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations